TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02793778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03947567 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT01306032 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02779881 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02779881 — Predictive Biomarker (PRD): FOXP3 mRNA
Genes: FOXP3; IPEX; JM2
Study NCT00725231 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT04443777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT00904878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01429935 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study NCT04432298 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT03972098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02793414 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04354441 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02264171 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02264171 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02692261 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02256800 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02256800 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01681303 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03823885 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01205737 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03445845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03445845 — Predictive Biomarker (PRD): TNFR1B
Genes: TNFRSF1B; TNFBR; TNFR80; TNF-R75; TNF-R-II; p75; CD120b
Study NCT02968875 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02316132 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT00063999 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02620709 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01693718 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT03745235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03774472 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03774472 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04811001 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04811001 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00098293 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04168138 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00134498 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03077308 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT03077308 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT03077308 — Predictive Biomarker (PRD): FOXG1 mRNA
Genes: FOXG1; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C
Study NCT01204372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01204372 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01204372 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02660346 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04433026 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04433026 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02452268 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT03797326 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04359706 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01044693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02881710 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT02881710 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT02881710 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03048942 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03212807 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01426555 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03878069 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT02620865 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02620865 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02953457 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02953457 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01671774 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02983058 — Predictive Biomarker (PRD): CNTNAP2 mRNA
Genes: CNTNAP2; CASPR2; KIAA0868
Study NCT04274465 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03139630 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04505150 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01553500 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01493141 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00660959 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00148538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00499434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04928066 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT00327431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00327431 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02555358 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04320277 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04320277 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03043820 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03090035 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT04366583 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04169412 — Predictive Biomarker (PRD): RIPK3 mRNA
Genes: RIPK3; RIP3
Study NCT00435994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03178799 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00887978 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03516955 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04640987 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03246555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02129010 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03303287 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02813824 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT02813824 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT01494857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02872142 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02872142 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03156621 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03156621 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03156621 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03424317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03010722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00353574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02614664 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00664677 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study NCT02373163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00997191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03587103 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03090659 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03342456 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04545489 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04195477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00382213 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01149343 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT01596530 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02003209 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02003209 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02003209 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01266083 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04162366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03059472 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01010854 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03977610 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02178072 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03760666 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT03292978 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT05019807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01395537 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01395537 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02744014 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01081717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04094610 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04094610 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04094610 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04094610 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study NCT03416933 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00601016 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03153293 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04605588 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01865045 — Predictive Biomarker (PRD): Tubulin beta-3 chain
Genes: TUBB3; TUBB4
Study NCT02729805 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02729805 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT02072382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03788928 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03788928 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT03614585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02246036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01820104 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01121458 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01121458 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01178515 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01033370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00066209 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01311011 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT04370847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04370847 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04346238 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT00000350 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00499538 — Predictive Biomarker (PRD): SKI mRNA
Genes: SKI
Study NCT01450267 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00027157 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03254641 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01930929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04501224 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02060188 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04401475 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study NCT04401475 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03093870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03093870 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT03093870 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04082676 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02864914 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02864914 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00224354 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00224354 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04720833 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00890097 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02608346 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02608346 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02608346 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01249287 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03898609 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03898609 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03898609 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03898609 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03898609 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06055595 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05652140 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01407601 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT01410487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04506775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00388323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00388323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00388323 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00388323 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT01260415 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02504385 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT02072512 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03130712 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT00677378 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT02197988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03706612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03680131 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT02536339 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06695442 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00163904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00163904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00163904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00646568 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT03737994 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02912611 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03932786 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT03932786 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT04457778 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04457778 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05511688 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05511688 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05511688 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT05511688 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03723525 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04165902 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03767114 — Predictive Biomarker (PRD): ERAP1 mRNA
Genes: ERAP1; APPILS; ARTS1; KIAA0525; UNQ584/PRO1154
Study NCT03722628 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT03722628 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT00860431 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02451033 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02451033 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT01892644 — Predictive Biomarker (PRD): Liver iron
Study NCT00862277 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT01600911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03074851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04209803 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03608007 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03608007 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT02467855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01270958 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03470857 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04877665 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00109070 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03874858 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03874858 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03031730 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT00510471 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02809781 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00738829 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03975647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00667836 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00221351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00722709 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01553071 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04082442 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04359693 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04217057 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT02096965 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02584413 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03663140 — Predictive Biomarker (PRD): TAC1 mRNA
Genes: TAC1; NKA; NKNA; TAC2
Study NCT03663140 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT04309838 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03491930 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03294954 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00364819 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01395641 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT00696436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03795740 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04040231 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04465487 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364